NCT06551064CompletedPhase 1
Assessment of Pharmacokinetic Similarity of FYB206 in Comparison with Keytruda in Resected Stage II or Stage III Melanoma Patients
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Feb 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 116 (actual)
- First submitted
- 3 May 2024
- Start date
- 21 Oct 2024
- Lead sponsor
- Formycon AG
- Diseases
- Melanoma
- EU CT number
- 2023-509765-20-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 116
- 9 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uniteversity Muliprofile Hospital For Active Treatment Tsaritsa Yoanna-Isul EAD Coordinator of this site? Confirm its status | Sofia | Bulgaria | Completed |
| Multiprofile Hospital for Active Treatment Sveta Sofia Coordinator of this site? Confirm its status | Sofiya | Bulgaria | Completed |
| Tartu University Hospital Coordinator of this site? Confirm its status | Tartu Linn | Estonia | Completed |
| Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos Coordinator of this site? Confirm its status | Kaunas | Lithuania | Completed |
| Krakowskie Centrum Medyczne Sp. z o.o. Coordinator of this site? Confirm its status | Cracow | Poland | Completed |
| IP Clinic Sp. z o.o. Coordinator of this site? Confirm its status | Lodz | Poland | Completed |
| ARENSIA Exploratory Medicine S.R.L. Coordinator of this site? Confirm its status | Bucharest | Romania | Completed |
| Arensia Clinics S.R.L. Coordinator of this site? Confirm its status | Bucharest | Romania | Completed |
| Centrul De Oncologie SF Nectarie S.R.L. Coordinator of this site? Confirm its status | Craiova | Romania | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.